SEC Form 4 · accession 0001485616-26-000006
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bridgette P Heller
Director
Period of report
Aug 12, 2026
Accepted (ET)
Aug 13, 2026 · 4:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 12, 2026 | S | 1,012 | $88.29 | D | 29,570 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- F2Included in this number are 5,575 unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders.